Popular antacid Digene gel receives warning alert from DCGI, Abbott initiates recall

The popular antacid Digene gel has received a warning alert from the Drugs Control General of India (DCGI) following which batches of the product have been recalled by its parent company Abbott India.

Issuing a cautionary advisory, the regulatory body has urged patients to discontinue the use of Digene Gel manufactured at Abbott's Goa facility. Furthermore, it has directed wholesalers to withdraw any affected product, including all batch numbers manufactured at the facility that are within their active shelf life, from distribution.

For more details, check out the link given below:

DCGI Flags Popular Antacid Digene Gel, Abbott Initiates Recall